Filters: Author is Mullins, J J [Clear All Filters]
Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. The Journal of clinical investigation. 1996;98:1966-70.
Variegated expression of a mouse steroid 21-hydroxylase/beta- galactosidase transgene suggests centripetal migration of adrenocortical cells. Molecular endocrinology (Baltimore, Md.). 1996;10:585-98.
Use of fiber optic technology to measure the effects of anesthesia on luciferase reaction kinetics. J Am Assoc Lab Anim Sci. 2012;51(6):820-4.
A urine-concentrating defect in 11β-hydroxysteroid dehydrogenase type 2 null mice. Am J Physiol Renal Physiol. 2012;303(4):F494-502.
Tumor necrosis factor-alpha activates the human prolactin gene promoter via nuclear factor-kappaB signaling. Endocrinology. 2006;147:773-81.
Transition from organogenesis to stem cell maintenance in the mouse adrenal cortex. Organogenesis. 2011;7(4).
Transient renin-angiotensin system stimulation in an early stage of life causes sustained hypertension in rats. J Hypertens. 2011;29(12):2369-80.
Transient induction of ANG II-dependent malignant hypertension causes sustained elevation of blood pressure and augmentation of the pressor response to ANG II in CYP1A1-REN2 transgenic rats. The American journal of the medical sciences. 2010;339:543-8.
Transgenics and essential hypertension. Journal of human hypertension. 1996;10:627-31.
Transgenic rats: new animal models in hypertension research. Invited lecture. Hypertension. 1991;17(6 Pt 2):843-55.
A transgenic model of visceral obesity and the metabolic syndrome. Science (New York, N.Y.). 2001;294:2166-70.
Transgenic approaches to modification of cell and tissue function. Current opinion in cell biology. 1991;3:192-8.
Transgenic animals: new approaches to hypertension research. Journal of hypertension. Supplement : official journal of the International Society of Hypertension. 1990;8:S35-7.
Transgenic animals in hypertension and cardiovascular research. Experimental nephrology. 1993;1:3-12.
Transgenic animals as models for human disease–report of an EC Study Group. Transgenic research. 1993;2:286-99.
Transgenic animal models of cardiovascular disease. Current opinion in biotechnology. 1992;3:637-40.
Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. The Journal of clinical investigation. 2003;112:83-90.
Transgenesis in the rat. Methods in molecular biology (Clifton, N.J.). 2002;180:255-70.
Transgenesis in nonmurine species. Hypertension. 1993;22:630-3.
Transcriptional and physiological responses to chronic ACTH treatment by the mouse kidney. Physiological genomics. 2010;40:158-66.
Tissue-specific modulation of glucocorticoid action by the 11 beta-hydroxysteroid dehydrogenases. Biochemical Society transactions. 1997;25:583-7.
The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors. Journal of human hypertension. 1989;3 Suppl 1:63-70.
Tissue and cell specific expression of a renin promoter-reporter gene construct in transgenic mice. Biochemical and biophysical research communications. 1990;170:344-50.
Techniques for the in vivo assessment of cardio-renal function in zebrafish (Danio rerio) larvae. The Journal of physiology. 2012.
Targeted inactivation of the Ren-2 gene in mice. Hypertension. 1996;28:1126-31.